Karachi: Development of medicine for COVID-19 patients at important stage
Last updated on: 21 November,2020 09:35 pm
Karachi: Development of medicine for COVID-19 patients at important stage
KARACHI (Dunya News) - The development of a medicine for Coronavirus patients has entered an important stage at Dow University in Karachi. A successful clinical trial of life-saving drug is underway at the University.
According to the doctors, the recovery of the critically ill patients of Coronavirus in the ICU was 60% while the recovery from CIVIG in the critically ill patients of Coronavirus was 100%.
The university announced the intravenous immunoglobulin in the second week of April. Injection is prepared by extracting antibodies from the plasma of recovered patients of coronavirus.
Pakistan has reported 42 deaths in the last 24 hours by novel coronavirus as the number of positive cases has surged to 371,508. The nationwide tally of fatalities has jumped to 7,603 on Saturday.
According to the latest figures by the National Command and Operation Center (NCOC), 2,843 persons tested positive for COVID-19 in the past 24 hours.
Sindh remains the worst-hit province by the pandemic in terms of cases followed by Punjab, Khyber Pakhtunkhwa and Balochistan. Punjab has overtaken Sindh in most number of casualties.
Till now 161,028 coronavirus cases have been confirmed in Sindh, 113,457 in Punjab, 43,730 in Khyber Pakhtunkhwa, 16,699 in Balochistan, 26,177 in Islamabad, 5,911 in Azad Kashmir and 4,506 in Gilgit-Baltistan.